The current legislation would put patients at risk, slow the development of effective stem cell therapies, and block the Food and Drug Administration (FDA) from access to crucial data about the safety and effectiveness of new medical treatments.Full story
- 14 February, 2018
Message from the President
Hubrecht Institute, the Netherlands
There is no better host city for the ISSCR 2018 annual meeting than Melbourne, Australia, a global hub of innovation in science and biotech with a rich stem cell history, flourishing research culture, and inspiring natural beauty and art.
Registration is open for the meeting, scheduled for 20-23 June at the Melbourne Convention & Exhibition Centre, Melbourne, Australia.
stem cell researchTake a closer look
Novel Stem Cell Therapy Grows New Skin
Imagine skin so fragile that rubbing or scratching it can lead to severe blistering and massive wounds. Patients with a rare genetic disease known as junctional epidermolysis bullosa (JEB) suffer from just this painful phenomenon.
Stem Cells in the News
Media highlights in the field of stem cell research and its translation to the clinic.
15 February, TheScientist
14 February, Phys.org
9 February, Medical Xpress
8 February, Medical Xpress
A sampling of recent stem cell research commentaries, articles, and resources.
Featured Current Protocols in Stem Cell Biology Article
Single-Cell Functional Analysis of Stem-Cell Derived Cardiomyocytes on Micropatterned Flexible Substrates. Kijlstra, J.D., Hu, D., van der Meer, P., and Domian, I.J. (2017).Current Prot. Stem Cell Biol. 43, 1F.20.1-1F.20.9.
CRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency. Liu, P., Chen, M., Liu, Y., Qi, L.S., and Ding, S. (2018), Cell Stem Cell , 22, 252-261.e4.
- , Melbourne
Seeking a job? Have a job opening? the ISSCR Job Board gives members discounts on job postings here and in the monthly Pulse e-newsletter.
Other Stem Cell Events
Opportunities for researchers from around the world to explore the latest discoveries in stem cell science and regenerative medicine.
ISSCR and policy news from around the world.
11 February, San Francisco Chronicle
State Earns First Royalty Check After Investing Billions in Stem Cell Research (CA)
6 February, Regulatory Focus
EMA Updates on Advanced Therapy Evaluations, Risk Management
22 January, Gizmodo
China Has Already Gene-Edited 86 People With CRISPR
11 December, BioSpectrum (Asia)
Korea to Ease Regulations on Biotech
Learn about ISSCR colleagues in the stem cell field from around the world.
Nils Pfaff, PhD
PhD in Molecular Medicine from Hannover Medical School
Lab Head Preclinical Pharmacology, Bayer AG (Wuppertal, Germany)